Downey, CA – SuperCare Health, the premier home medical and respiratory provider for utilization management and managing high-risk respiratory patients in the home in the western US, has renewed its contract with Optum as a provider of respiratory care services, equipment, and supplies for its members in Southern California. The renewal solidifies the history of partnership between the two healthcare organizations to enhance patient care and improve both financial and clinical outcomes.
“We are honored that Optum has extended our contract. This continues to strengthen our long term partnership with Optum and it will bring even more innovative solutions like our COVID-19 Telemonitoring, iBreathe, and Home Sleep Testing Programs that drive positive patient outcomes for those dealing with chronic conditions.” said John Cassar, CEO, SuperCare Health. “Optum has been a pioneer with many of the innovative care management programs SuperCare Health has developed to help patients manage their disease while also enabling cost savings for hospitals and health systems.”
SuperCare Health quickly developed a COVID-19 Telemonitoring Program for Optum to manage those impacted by COVID-19 who could recover in their own homes, enabling more available beds for those facing more critical infections. Patients referred to the program were provided with oxygen therapy, remote monitoring equipment and respiratory therapist support during the initial period. SuperCare Health’s respiratory team monitored their health status, escalating critical situations back to the patient’s clinical care team as appropriate. Post-program surveys revealed 100 percent of patients enrolled in the program felt that they were better able to manage their health from being in the program.
SuperCare Health and Optum also partnered on an IRB-approved clinical trial for high-risk COPD patients that examined if a SuperCare Health-developed care management program for COPD patients affected hospitalization rates for those high-risk patients. The results validated SuperCare Health’s iBreathe program as an effective and efficient intervention that reduced all-cause hospital admissions by 37.5 percent and total length of stay for COPD hospitalizations by 48 percent. The study demonstrated health plan savings of up to $1.2 million with just 250 enrolled patients, making SuperCare Health the only HME with an IRB study.
SuperCare Health is the leading provider of in-home respiratory services of respiratory care in California and the western U.S, supporting the needs of patients with COPD, CHF, COVID-19 and chronic respiratory conditions all through an in-home high touch approach with cutting-edge devices. SuperCare Health has been awarded preferred and capitated contracts based on its positive clinical and financial outcomes to provide a broad range of therapies, including oxygen, CPAP/BiPAP, ventilation, and home medical equipment.
Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 190,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE: UNH). For more information, visit www.Optum.com.
About SuperCare Health
SuperCare Health is a comprehensive, high-touch, high-tech, post-acute health care organization that manages chronic care patients and provides a broad range of respiratory therapies, including ventilation, oxygen, CPAP/BiPAP, medication optimization, and airway clearance and mobilization. Utilizing cutting-edge mobile technologies combined with quality clinical services, SuperCare Health has proven cost savings that reduce hospital readmissions and offer shared savings for payors. For more information, visit www.supercarehealth.com